This study introduces G-protein-coupled receptor-associated sorting protein 1 (GASP-1) as a potential biomarker for the detection of prostate cancer (PCa), aiming to address the limitations of current diagnostic tools, primarily serum prostate-specific antigen (PSA) levels. This evidence concerns the gene GPRASP1 and posterior cortical atrophy.